Simaniv TO, Kochergin IA, Zakharova MN, Korobko DS, Zaslavskii LG, Zelenova OV, Abramov SI. [Clinical and epidemiological aspects of neuromyelitis optic spectrum diseases in the russian population].
Zh Nevrol Psikhiatr Im S S Korsakova 2021;
121:96-103. [PMID:
34460164 DOI:
10.17116/jnevro202112107196]
[Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
OBJECTIVE
To present clinical and epidemiological aspects of neuromyelitis optica spectrum disorders (NMOSD) in the Russian Federation.
MATERIAL AND METHODS
We studied 142 patients who met diagnostic criteria of 2015 for NMOSD. Sex, age at disease onset, presence or absence of aquaporin-4 immunoglobulin G antibodies (AQP4-IgG), mail clinical symptoms, oligoclonal IgG, therapy for the treatment of exacerbations and prevention of exacerbations, compliance with 2006 diagnostic criteria were assessed.
RESULTS
The prevalence of women is 4.26:1, the most frequent age at disease onset is 18-29 years (36% of cases). The laboratory aspects of the disease are characterized and approaches to the treatment and prevention of exacerbations of NMOSD in patients of the Russian population are evaluated. Approaches to diagnostics are compared depending on the applied diagnostic criteria (34% of patients do not meet neuromyelitis optica 2006 diagnostic criteria). A prognosis for the prevalence of NMOSD in the Russian population has been proposed: 0.45-4.21/100000.
CONCLUSION
This is the first published data on clinical and epidemiological characteristics of NMOSD in the Russian Federation.
Collapse